Sensus Healthcare, Inc. (SRTS) Stock Analysis
A live, multi-source view of Sensus Healthcare, Inc. (SRTS): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Sensus Healthcare, Inc.
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles.
Sector: Healthcare · Industry: Medical Devices · United States · 60 employees · sensushealthcare.com
Key statistics · as of 2026-09-06
As of 2026-09-06, Sensus Healthcare, Inc. (SRTS) had a market capitalization of $52.5M (forward -18.4) and a beta of 1.14; the shares traded in a 52-week range of $2.66 – $5.49 (-1.2% over the year).
- Market cap
- $52.5M
- Enterprise value
- $37.7M
- Forward P/E
- -18.4
- Price / book
- 1.42
- EPS (trailing)
- $-0.94
- EPS (forward)
- $-0.17
- Payout ratio
- 0.0%
- 52-week range
- $2.66 – $5.49
- 52-week change
- -1.2%
- Beta
- 1.14
- Average volume
- 34,450
- Shares outstanding
- 16.5M
- Short % of float
- 1.41%
- Profit margin
- -88.5%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-10
In RapidTradeView’s 2026-09-10 scan of the US universe, Sensus Healthcare, Inc. (SRTS) last closed at $3.12 (the last completed close before that scan).
Technicals at the scan: RSI 46 (neutral territory), price -3.4% versus its 20-day average, 20-day versus 50-day average spread +4.2%, MACD histogram -0.03.
Sentiment inputs: StockTwits 88% bullish; analyst consensus score 81/100.
Next scheduled company event: in 56 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 0 buys and 0 sells of SRTS; corporate insiders filed 8 buys and 0 sells (2 distinct filers, latest disclosure 2026-08-31). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Eric Sachetta (7B/0S), Joseph C. Sardano (1B/0S). Who is trading what
RapidTradeView pick record
SRTS has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Sensus Healthcare, Inc. (SRTS) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell SRTS.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.